|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 304, Issue 3, 913-923, March 2003
Parkinson's Disorder Research Laboratory, Department of Biomedical
Sciences, Iowa State University, Ames, Iowa (L.M., V.A., A.G.K.); and
Cellular Neurobiology Branch, National Institute on Drug Abuse,
Baltimore, Maryland (W.J.F.)
Apoptosis and glutamate-mediated excitotoxicity may play a role in the
pathogenesis of many neurodegenerative disorders, including Parkinson's disease (PD). In the present study, we investigated whether stimulation of the 5-hydroxytryptamine 1A (5-HT1A) receptor attenuates N-methyl-D-aspartate- (NMDA) and
1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell
death in cell culture models. A brief exposure (20 min) of M213-2O
striatal cells to NMDA and glutamate produced a delayed increase in
caspase-3 activity and DNA fragmentation in a dose- and time-dependent
manner. NMDA-induced caspase-3 activity and DNA fragmentation were
almost completely blocked by the 5-HT1A agonists
8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) and (R)-5-fluoro-8 hydroxy-2-(dipropylamino)-tetralin
(R-UH-301). Additionally, the protective effects of
8-OH-DPAT and R-UH-301 on NMDA-induced caspase-3
activation and apoptosis were reversed by pretreatment with the 5-HT1A
antagonists N-[2-[4-(2-methoxyphenyl)-1-piperazinyl] ethyl]-N-(2-pyridinyl) cyclohexane carboxamide (WAY
100635) and S-UH-301, respectively. Similarly, dose- and
time-dependent increases in caspase-3 activity and DNA fragmentation
were observed in rat primary mesencephalic neurons after a brief
exposure to NMDA and glutamate. Caspase-3 activation and DNA
fragmentation in primary mesencephalic neurons were almost completely
inhibited by 8-OH-DPAT. This neuroprotective effect of 8-OH-DPAT was
reversed by WAY 100635. Additionally, 8-OH-DPAT blocked tyrosine
hydroxylase (TH)-positive cell death after NMDA exposure and also
almost completely attenuated the NMDA-induced Ca2+ influx
in primary mesencephalic cultures. Furthermore, 8-OH-DPAT and
R-UH-301 blocked apoptotic cell death in the primary
mesencephalic neurons that were exposed to the Parkinsonian toxin
MPP+. Together, these results suggest that 5-HT1A receptor
stimulation may be a promising pharmacological approach in the
development of neuroprotective agents for PD.
This article has been cited by other articles:
![]() |
C.-N. Wang, H.-C. Pan, Y.-L. Lin, C.-W. Chi, and Y.-J. Shiao Ester Derivatives of Tournefolic Acid B Attenuate N-Methyl-D-aspartate-Mediated Excitotoxicity in Rat Cortical Neurons Mol. Pharmacol., March 1, 2006; 69(3): 950 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mishima, K. Hayakawa, K. Abe, T. Ikeda, N. Egashira, K. Iwasaki, and M. Fujiwara Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine1A Receptor-Dependent Mechanism Stroke, May 1, 2005; 36(5): 1071 - 1076. [Abstract] [Full Text] [PDF] |
||||